Terkko Navigator / Lancet Respiratory Medicine

Pneumonia research: time to fill in the gaps

Pulse oximetry in paediatric primary care in low-income and middle-income countries

E-cigarette use in Great Britain

Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunities

Pulmonary embolism in Europe remains a cause of concern despite declining deaths

Next-generation ALK inhibitors: is the median the message?

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Primary ciliary dyskinesia in the genomics age

Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database

India launches tuberculosis prevalence survey

2019 European Respiratory Society International Congress

Breakthrough in the treatment of drug-resistant tuberculosis

Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study

Towards improved delivery of care in the paediatric ICU

Vaping-induced severe respiratory disease outbreak: what went wrong?

Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial

The long-lasting dark shadow of past and present smoking

Is ex-vivo viral eradication possible?

Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group

Secondary re-analysis of the FEAST trial

Harnessing the microbiome for lung health

IASLC 2019 World Conference on Lung Cancer

US Government contemplates a nationwide ban on flavoured e-cigarette products

Michigan bans flavoured e-cigarette products

Idiopathic pulmonary fibrosis: shifting the concept to irreversible pulmonary fibrosis of many entities

Repeat proposal from the FDA for graphic tobacco warnings

E-cigarettes and dual nicotine replacement therapy for smoking cessation

Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial

Lung volume reduction on the NHS

Occupational exposures are important factors in COPD and other lung diseases

To eliminate racial and ethnic disparities in child health care, more needs to be addressed than just social determinants

US state governments investigate suspected vaping-associated severe lung disease

Correction to Lancet Respir Med 2019; published online Aug 16. http://dx.doi.org/S2213-2600(19)30281-4

Individualising therapy for drug-sensitive tuberculosis

Breathless and dying on Mount Everest

What's BEST for children with non-cystic fibrosis bronchiectasis?

Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial

When is the right time to discuss ECMO?

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial

Pulmonary hypertension associated with idiopathic interstitial pneumonia: is effective pharmacotherapy an impossible dream?

Prospects and challenges of a new live tuberculosis vaccine

Insights and challenges in tuberculosis vaccine development

Raising new questions on best care for bronchiectasis

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis

Treatment duration of checkpoint inhibitors for NSCLC

Personalised mechanical ventilation tailored to lung morphology versus low positive end-expiratory pressure for patients with acute respiratory distress syndrome in France (the LIVE study): a multicentre, single-blind, randomised controlled trial

A new frontier in ARDS trials: phenotyping before randomisation

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study